|
| |
AEterna Laboratories quebec Pages on BioPortfolio:
BioPortfolio - AEterna Laboratories Incorporated - Profile
BACKGROUND: AE-941 (Neovastat) is an angiogenesis inhibitor noted to have...1st July, 2005. AEterna Laboratories, Quebec, Quebec, Canada.- J Cutan Med Surg. ...
http://www.bioportfolio.com/biocorporate/212-AEterna+Laborat...
|
BioPortfolio - AEterna Zentaris - Profile
Products on the market Æterna Zentaris. Inc., the "Company" formed following the acquisition of German-based company Zentaris by Æterna. Laboratories Inc. ...
http://www.bioportfolio.com/biocorporate/32339-AEterna+Zenta...
|
BioPortfolio - neovastat
Among the new antiangiogenic drugs in development, Neovastat (AE-941; Aeterna Laboratories, Quebec City, Canada) can be classified as a naturally occurring
...
http://www.bioportfolio.com/search/neovastat.html...
|
BioPortfolio - Biocorporate Search Quebec
Biocorporate Search Quebec - Entry on Bioportfolio's Biocorporate Database. ... Æterna Laboratories Inc. is a biopharmaceutical company focused on the ...
http://www.bioportfolio.com/biocorporate/search/region/Quebe...
|
BioPortfolio - excel labs canada
Recent Search Terms used to find this page: aeterna laboratories canada . ... Paladin Labs Inc., 102-6111 Royalmount Avenue, Montreal, Quebec, Canada, . ...
http://www.bioportfolio.com/search/excel_labs_canada.html...
|
BioPortfolio - CAESA-LAB Inc. - Profile
Quebec. J3V 6J9. Canada. Tel: 450-441-5408. Fax: 450-441-9167 ... SmartBrief: Nov 13 2008 2:39PM Matching: lab inc. • AEterna Zentaris Gets $52.5M from ...
http://www.bioportfolio.com/biocorporate/35139-CAESA-LAB+Inc...
|
BioPortfolio - Paladin - Profile
13 Nov 2008 ... Paladin Labs Inc., 102-6111 Royalmount Avenue, Montreal, Quebec, ... AEterna Zentaris Gets $52.5M from Cetrotide Royalty Sale ...
http://www.bioportfolio.com/biocorporate/8025-Paladin.pdf...
|
BioPortfolio - Paladin
Paladin Labs Inc., 102-6111 Royalmount Avenue, Montreal, Quebec, Canada,, J Environ Health. ... AEterna Zentaris Gets $52.5M from Cetrotide Royalty Sale ...
http://www.bioportfolio.com/biocorporate/8025-Paladin.html...
|
Results from other life science and pharmaceutical sites:
BioPortfolio - AEterna Laboratories Incorporated - Profile
BACKGROUND: AE-941 (Neovastat) is an angiogenesis inhibitor noted to have...1st July, 2005. AEterna Laboratories, Quebec, Quebec, Canada.- J Cutan Med Surg. ...
http://www.bioportfolio.com/biocorporate/212-AEterna+Laborat...
|
Æterna Zentaris Inc
Québec City, Quebec, April 2, 2004 - Æterna Laboratories Inc. (TSX: AEL ; NASDAQ : AELA) announced that its wholly owned subsidiary Zentaris GmbH and Ardana ...
http://www.aeternazentaris.com/en/page.php?p=60&q=47...
|
New Appointment to AEterna Management
QUEBEC CITY, Sept. 13 /PRNewswire-FirstCall/ - AEterna Laboratories Inc. (TSX: AEL; Nasdaq: AELA), today announced the appointment of Mr. Claude Cardinal as
...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=...
|
Æterna Zentaris Inc
Québec City, December 18, 2002 - Dr. Éric Dupont, Chairman of the Board and CEO of Æterna Laboratories Inc. (TSX: AEL; NASDAQ: AELA) today announced that he ...
http://www.aeternazentaris.com/en/page.php?p=60&q=11...
|
BioCentury - Aeterna Zentaris Inc. - Company Profile
formerly known as Aeterna Laboratories Inc. Print preview Print preview. General Information. Location, Quebec City, Quebec. Region, Quebec. Country, Canada ...
http://www.biocentury.com/companies/Aeterna_Zentaris_Inc...
|
Æterna Zentaris Inc
Québec City, Quebec, April 7, 2004 - Æterna Laboratories Inc. (TSX: AEL; Nasdaq: AELA) along with its wholly-owned subsidiary Zentaris GmbH, announced today ...
http://www.aeternazentaris.com/en/page.php?p=60&q=48...
|
Neovastat, a naturally occurring multifunctional a...[Semin Oncol ...
Among the new antiangiogenic drugs in development, Neovastat (AE-941; Aeterna Laboratories, Quebec City, Canada) can be classified as a naturally occurring
...
http://www.ncbi.nlm.nih.gov/pubmed/11740820...
|
Æterna Zentaris Inc
Québec City, January 28, 2003 - Dr. Éric Dupont, Chairman of the Board of Æterna Laboratories Inc. (TSX: AEL; NASDAQ: AELA) today announced the following ...
http://www.aeternazentaris.com/en/page.php?p=60&q=37...
|
{1} Updates Neovastat's Clinical Development Plan; Ceases All ...
QUEBEC CITY, Dec. 17 /PRNewswire-FirstCall/ -- Gilles Gagnon, President and Chief Executive Officer at AEterna Laboratories Inc. (TSX: AEL; Nasdaq: AELA)
...
http://www.biospace.com/news_story.aspx?NewsEntityId=1466982...
|
Æterna Zentaris Inc
QUÉBEC CITY, Canada, September 24, 2003 - Æterna Laboratories Inc. (TSX: AEL; Nasdaq: AELA) today reported results of a Phase III trial in renal cell ...
http://www.aeternazentaris.com/en/page.php?p=60&q=46...
|
|
